World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
118
Citations
51276
World Ranking
4062
National Ranking
2225

Research.com Recognitions

  • 1996 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Emil J. Freireich was affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research career was associated with this institution, contributing to the academic and clinical environment there.

The scientist's recognized professional memberships included being a Fellow of the American Association for the Advancement of Science (AAAS), awarded in 1996. Additionally, they were a member of the Association of American Physicians.

There are no recorded recent papers, frequent co-authors, publication venues, book publications, or specific fields and subfields of study available in the data.

Best Publications

  • Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

    Gerald P. Bodey;Monica Buckley;Y. S. Sathe;Emil J Freireich

  • Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

    Freireich Ej;Gehan Ea;Rall Dp;Schmidt Lh

  • Flow Cytometry in Clinical Cancer Research

    Barthel Barlogie;Martin N. Raber;Johannes Schumann;Tod S. Johnson

  • Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion.

    Sewa S. Legha;Robert S. Benjamin;Bruce Mackay;Michael Ewer

  • Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

    Alvaro Aguayo;Hagop M Kantarjian;Taghi Manshouri;Cristi Gidel

  • Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

    Hagop M Kantarjian;Susan O'Brien;Terry L. Smith;Jorge E Cortes

  • Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

    Hagop Kantarjian;Deborah Thomas;Susan O'Brien;Jorge Cortes

  • Rituximab Dose-Escalation Trial in Chronic Lymphocytic Leukemia

    Susan M. O’Brien;Hagop Kantarjian;Deborah A. Thomas;Francis J. Giles

  • Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

    M. J. Keating;Hagop M Kantarjian;M. Talpaz;J. Redman

  • Causes of Death in Acute Leukemia: A Ten-Year Study of 414 Patients From 1954-1963.

    Evan M. Hersh;Gerald P. Bodey;Boyd A. Nies;Emil J Freireich

  • Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.

    M. J. Keating;S. O'Brien;S. Lerner;C. Koller

  • Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.

    Hagop Kantarjian;Susan O'Brien;Farhad Ravandi;Jorge Cortes

  • Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia

    Philip A. Thompson;Constantine S. Tam;Susan M. O'Brien;William G. Wierda

  • Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification

    Ming Sheng Lee;Kun Sang Chang;Fernando Cabanillas;Emil J. Freireich

  • Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia.

    Hagop M. Kantarjian;Farhad Ravandi;Susan OBrien;Jorge Cortes

  • Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.

    Hagop M Kantarjian;Varsha Gandhi;Jorge Cortes;Srdan Verstovsek

  • Cellular DNA content as a marker of neoplasia in man.

    Barthel Barlogie;Benjamin Drewinko;Johannes Schumann;Wolfgang Göhde

  • Causes of death in adults with acute leukemia.

    Hui Yen Chang;Victorio Rodriguez;Gino Narboni;Gerald P. Bodey

  • Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients

    Hagop M. Kantarjian;Michael J. Keating;Moshe Talpaz;Ronald S. Walters

  • The Effectiveness of Combinations of Antileukemic Agents in Inducing and Maintaining Remission in Children with Acute Leukemia

    E. Frei;M. Karon;R. H. Levin;E. J. Freireich

Frequent Co-Authors

Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Michael J. Keating
Michael J. Keating The University of Texas MD Anderson Cancer Center
Susan O'Brien
Susan O'Brien University of California, Irvine
Gerald P. Bodey
Gerald P. Bodey The University of Texas MD Anderson Cancer Center
Elihu H. Estey
Elihu H. Estey University of Washington
Jorge E. Cortes
Jorge E. Cortes Augusta University
Sherry Pierce
Sherry Pierce The University of Texas MD Anderson Cancer Center
Francis J. Giles
Francis J. Giles Northwestern University
Moshe Talpaz
Moshe Talpaz University of Michigan–Ann Arbor
Jordan U. Gutterman
Jordan U. Gutterman The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a doctor. There are various online degree programs and alternative pathways that can lead to a rewarding future in healthcare. Many students consider the easiest rn program options to jumpstart their nursing careers, providing a more accessible entry into healthcare roles.

For registered nurses looking to expand their qualifications, there are cheap rn to bsn online programs available. These accredited programs allow nurses to earn their Bachelor of Science in Nursing at a lower cost and with greater flexibility, making advancement more achievable.

Even individuals with non-nursing backgrounds can transition into the field through options like the non nursing bachelor's to msn online pathway. These direct-entry Master of Science in Nursing programs are designed for those who hold degrees in other fields but want to become advanced practice nurses.

For those seeking terminal degrees, the online nursing doctorate offers opportunities to move into research, teaching, or high-level leadership positions in healthcare. These advanced degrees can typically be earned online, adding both convenience and affordability.

Best Scientists Citing Emil J. Freireich